Position in YCBD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16
+$4 QoQ
Shares Held
22
+1000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in YCBD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
96,662,102 | $1,534,994,177 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
56,948,819 | $1,401,510,433 | |
| 3 | HLN |
Haleon plc
|
120,991,250 | $1,128,848,360 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
30,258,016 | $1,025,141,579 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
6,971,361 | $445,818,534 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,879,971 | $430,443,982 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,727,909 | $300,433,243 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
473,409 | $256,507,196 |
All Filings in YCBD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16 | 22 | Shares | Defined | 2026-05-15 | |
| 2023-12-31 | $12 | 12 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16 | 16 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $1 | 9 | Shares | Defined | 2023-08-11 | |
| 2021-06-30 | $5 | 2 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||